Priority Date: 06.02.12 (FR 20120051089)

USE OF miR-199a-5p, TARGETS AND/OR INHIBITORS THEREOF FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF FIBROPROLIFERATIVE DISORDERS

  • Application ID: EP13712915
  • Status: █ EXAMINATION IN PROGRESS

Attorneys

Employment test 201 - 500 employees
Missing person image thumb Missing person image thumb Missing person image thumb
Company dna novagraaf
operating since 1888
951.09
Novagraaf
Headquarter in Amsterdam and 15 offices
active in Legal Services and IP Consulting
Missing person image thumb Missing person image thumb Missing person image thumb
Company dna novagraaf technologies
no operation time available
998.68
Novagraaf Technologies SA
3 offices
active in Legal Services

Specialization

This patent has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in C12. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 06.02.2012 - Priority Date (FR 20120051089)
  • 15.08.2013 - Publication A1 (WO2013118066)
  • 17.12.2014 - Publication A1 (EP2812449)

IPC Classification